| http://www.w3.org/ns/prov#value | - A growing appreciation of the latter has led hematopathologists and oncologists alike to adopt the term prognosis at diagnosis" in regard to CLL.The HemeScan test is an innovative approach to the management of CLL. In a single test, it assays all of the genomic loci for copy number aberrations currently measured by commercial multi-probe fluorescent in situ hybridization (FISH) kits.
|
